These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 8641222
1. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Rawlings SR, Hezareh M. Endocr Rev; 1996 Feb; 17(1):4-29. PubMed ID: 8641222 [No Abstract] [Full Text] [Related]
2. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate. Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC. Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902 [Abstract] [Full Text] [Related]
4. Pituitary adenylate cyclase-activating polypeptide and its receptors in amphibians. Yon L, Alexandre D, Montéro M, Chartrel N, Jeandel L, Vallarino M, Conlon JM, Kikuyama S, Fournier A, Gracia-Navarro F, Roubos E, Chow B, Arimura A, Anouar Y, Vaudry H. Microsc Res Tech; 2001 Aug 01; 54(3):137-57. PubMed ID: 11458398 [Abstract] [Full Text] [Related]
5. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC. Jamen F, Puech R, Bockaert J, Brabet P, Bertrand G. Endocrinology; 2002 Apr 01; 143(4):1253-9. PubMed ID: 11897681 [Abstract] [Full Text] [Related]
6. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H. Endocrinology; 1999 Mar 01; 140(3):1285-93. PubMed ID: 10067855 [Abstract] [Full Text] [Related]
7. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase. Nilsson SF, De Neef P, Robberecht P, Christophe J. Exp Eye Res; 1994 Apr 01; 58(4):459-67. PubMed ID: 7925682 [Abstract] [Full Text] [Related]
8. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states. Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M. Mol Pharmacol; 1996 Dec 01; 50(6):1596-604. PubMed ID: 8967982 [Abstract] [Full Text] [Related]
16. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development. Basille M, Vaudry D, Coulouarn Y, Jegou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez B. J Comp Neurol; 2000 Oct 02; 425(4):495-509. PubMed ID: 10975876 [Abstract] [Full Text] [Related]
18. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type I A receptor mRNAs in granulosa cells of preovulatory follicles of the rat ovary. Koh PO, Kwak SD, Kang SS, Cho GJ, Chun SY, Kwon HB, Choi WS. Mol Reprod Dev; 2000 Apr 02; 55(4):379-86. PubMed ID: 10694744 [Abstract] [Full Text] [Related]